Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre hospitalier de l'Université de Montréal (CHUM)
Chinese University of Hong Kong
Cairo University
Duke University
National Cancer Institute (NCI)
University Hospital, Tours
bioAffinity Technologies Inc.
Fondazione del Piemonte per l'Oncologia
Fondazione del Piemonte per l'Oncologia
Hôpital du Valais
Centre Oscar Lambret
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
Cairo University
University of Cadiz
The University of Hong Kong
Virginia Commonwealth University
Centre Oscar Lambret
Centre Oscar Lambret
Fred Hutchinson Cancer Center
Indiana University
Washington University School of Medicine
Tang-Du Hospital
Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)
Zhejiang University
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
Hackensack Meridian Health
Pusan National University Hospital
Bezmialem Vakif University
University of California, Davis
Guangzhou University of Traditional Chinese Medicine
University Hospital Heidelberg
Mayo Clinic
Vanderbilt-Ingram Cancer Center
University of Utah
Zealand University Hospital
University of Mississippi Medical Center
Guizhou Medical University
M.D. Anderson Cancer Center
University Hospital Heidelberg
University Hospitals Coventry and Warwickshire NHS Trust
University of Illinois at Chicago
Institut Bergonié
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Institute of Oncology Ljubljana
Ohio State University Comprehensive Cancer Center
University Health Network, Toronto
City of Hope Medical Center